Cargando…
COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
BACKGROUND: With the lack of effective therapy, chemoprevention, and vaccination against SARS-CoV-2, focusing on the immediate repurposing of existing drugs gives hope of curbing the COVID-19 pandemic. A recent unbiased genomics-guided tracing of the SARS-CoV-2 targets in human cells identified vita...
Autores principales: | Annweiler, Cédric, Beaudenon, Mélinda, Gautier, Jennifer, Simon, Romain, Dubée, Vincent, Gonsard, Justine, Parot-Schinkel, Elsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768266/ https://www.ncbi.nlm.nih.gov/pubmed/33371905 http://dx.doi.org/10.1186/s13063-020-04928-5 |
Ejemplares similares
-
High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial
por: Annweiler, Cédric, et al.
Publicado: (2022) -
Alzheimer's disease - input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial
por: Annweiler, Cédric, et al.
Publicado: (2011) -
Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study
por: Annweiler, Cédric, et al.
Publicado: (2021) -
Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study
por: Annweiler, Gaëlle, et al.
Publicado: (2020) -
Physical activity prescription for general practice patients with cardiovascular risk factors–the PEPPER randomised controlled trial protocol
por: Missud, David C., et al.
Publicado: (2019)